ATA784A - METHOD FOR PRODUCING A LOADED ION EXCHANGE RESIN AND THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS HIEMITE - Google Patents

METHOD FOR PRODUCING A LOADED ION EXCHANGE RESIN AND THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS HIEMITE

Info

Publication number
ATA784A
ATA784A AT0000784A AT784A ATA784A AT A784 A ATA784 A AT A784A AT 0000784 A AT0000784 A AT 0000784A AT 784 A AT784 A AT 784A AT A784 A ATA784 A AT A784A
Authority
AT
Austria
Prior art keywords
hiemite
producing
production
ion exchange
exchange resin
Prior art date
Application number
AT0000784A
Other languages
German (de)
Other versions
AT391467B (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ATA784A publication Critical patent/ATA784A/en
Application granted granted Critical
Publication of AT391467B publication Critical patent/AT391467B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0000784A 1983-01-12 1984-01-02 METHOD FOR PRODUCING A LOADED ION EXCHANGE RESIN AND THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS HIEMITE AT391467B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH14783A CH655507B (en) 1983-01-12 1983-01-12

Publications (2)

Publication Number Publication Date
ATA784A true ATA784A (en) 1990-04-15
AT391467B AT391467B (en) 1990-10-10

Family

ID=4180317

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0000784A AT391467B (en) 1983-01-12 1984-01-02 METHOD FOR PRODUCING A LOADED ION EXCHANGE RESIN AND THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS HIEMITE
AT84810008T ATE37378T1 (en) 1983-01-12 1984-01-06 RESINATE OF A SUBSTITUTED CARBON ACID, PROCESS FOR ITS PRODUCTION, ITS USE AND PHARMACEUTICAL PREPARATIONS CONTAINING IT.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT84810008T ATE37378T1 (en) 1983-01-12 1984-01-06 RESINATE OF A SUBSTITUTED CARBON ACID, PROCESS FOR ITS PRODUCTION, ITS USE AND PHARMACEUTICAL PREPARATIONS CONTAINING IT.

Country Status (41)

Country Link
US (1) US4510128A (en)
EP (1) EP0122219B1 (en)
JP (1) JPS59134759A (en)
KR (1) KR900006747B1 (en)
AR (1) AR240310A1 (en)
AT (2) AT391467B (en)
AU (1) AU570230B2 (en)
BE (1) BE898649A (en)
CA (1) CA1218077A (en)
CH (1) CH655507B (en)
CS (1) CS269954B2 (en)
DD (1) DD218373A5 (en)
DE (2) DE3474152D1 (en)
DK (1) DK166683B1 (en)
DZ (1) DZ593A1 (en)
EG (1) EG16562A (en)
ES (1) ES8504849A1 (en)
FI (1) FI82682C (en)
FR (1) FR2542735B1 (en)
GB (1) GB2134529B (en)
GR (1) GR79793B (en)
HK (1) HK90390A (en)
HU (1) HU190750B (en)
IE (1) IE56545B1 (en)
IL (1) IL70660A (en)
IT (1) IT1177501B (en)
LU (1) LU85171A1 (en)
MA (1) MA20000A1 (en)
MC (1) MC1564A1 (en)
MT (1) MTP943B (en)
NL (1) NL8400098A (en)
NO (1) NO162862C (en)
NZ (1) NZ206815A (en)
OA (1) OA07628A (en)
PH (1) PH21795A (en)
PL (1) PL142737B1 (en)
PT (1) PT77932B (en)
RO (1) RO88481A (en)
SE (1) SE457959B (en)
ZA (1) ZA84212B (en)
ZW (1) ZW484A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (en) * 1985-02-08 1988-02-15 Ciba Geigy Ag PHARMACEUTICAL PREPARATIONS WITH ANALGETIC EFFECTIVENESS AND THEIR PRODUCTION.
ES8604955A1 (en) * 1985-11-08 1986-03-16 Covex Sa Process for the preparation of (-) eburnamenin-14-(15H)-one resinates
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
CH675537A5 (en) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (en) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Long-acting diclofenac sodium preparations
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
EP0373103B1 (en) * 1988-11-10 1993-03-31 Ciba-Geigy Ag Liquid oral formulation
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (en) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech ANION EXCHANGER
JPH06509099A (en) * 1991-07-03 1994-10-13 サノ・コーポレーシヨン Compositions and methods for transdermal delivery of diclofenac
EP1250937B1 (en) * 2001-04-09 2009-05-13 Rohm And Haas Company Controlled dissolution of active ingredients
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
EP1830851A2 (en) * 2004-12-06 2007-09-12 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
RU2435569C2 (en) 2006-03-16 2011-12-10 Трис Фарма, Инк. Compositions with modified release, containing complexes medication-ion-exchanging resin
US7799347B2 (en) * 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
AU2009298112B2 (en) * 2008-10-02 2015-11-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Administration of an adsorbent polymer for treatment of systemic inflammation
CA2794171C (en) 2010-03-24 2018-07-03 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
BR112015003120B1 (en) 2012-08-15 2022-08-09 Tris Pharma , Inc METHYLPHENIDATE EXTENDED RELEASE CHEW TABLET AND ITS USE
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
UY37341A (en) 2016-07-22 2017-11-30 Flamel Ireland Ltd FORMULATIONS OF GAMMA-MODIFIED RELEASE HYDROXIBUTIRATE WITH IMPROVED PHARMACOCINETICS
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
JP7472116B2 (en) 2018-11-19 2024-04-22 ジャズ ファーマシューティカルズ アイルランド リミテッド Alcohol-resistant preparations
CN113473980A (en) 2019-03-01 2021-10-01 弗拉梅尔爱尔兰有限公司 Gamma-hydroxybutyrate compositions with improved pharmacokinetics in fed state
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
DK125461B (en) * 1967-12-20 1973-02-26 Ciba Geigy Ag Process for the preparation of substituted phenylacetic acids or salts thereof.
CH519476A (en) * 1968-03-30 1972-02-29 Hoechst Ag Process for the preparation of salts of acylamino-alkylbenzenesulphonyl ureas with anion exchangers
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (en) * 1976-05-25 1977-12-23 Viridis Ets NEW ANIONIC RESIN WITH HYPOCHOLESTEROLEMIANTE ACTION, ITS PREPARATION PROCESS AND THERAPEUTIC COMPOSITIONS CONTAINING IT
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (en) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa PHARMACOLOGICALLY ACTIVE SALONIZED ANIONIC RESIN BASED COMPOSITIONS
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
DK11884A (en) 1984-07-13
ZA84212B (en) 1984-08-29
CA1218077A (en) 1987-02-17
ES528770A0 (en) 1985-05-01
GB8400251D0 (en) 1984-02-08
LU85171A1 (en) 1984-10-24
NO162862B (en) 1989-11-20
DZ593A1 (en) 2004-09-13
CS269954B2 (en) 1990-05-14
FR2542735B1 (en) 1986-04-18
DK11884D0 (en) 1984-01-11
PH21795A (en) 1988-02-29
AU2323084A (en) 1984-07-19
GB2134529B (en) 1986-09-24
IL70660A0 (en) 1984-04-30
EP0122219B1 (en) 1988-09-21
MC1564A1 (en) 1984-11-12
IT8447527A0 (en) 1984-01-10
AU570230B2 (en) 1988-03-10
DE3474152D1 (en) 1988-10-27
SE457959B (en) 1989-02-13
FR2542735A1 (en) 1984-09-21
KR900006747B1 (en) 1990-09-20
PT77932A (en) 1984-02-01
IT1177501B (en) 1987-08-26
DE3400491A1 (en) 1984-07-12
SE8400098D0 (en) 1984-01-10
EG16562A (en) 1991-12-30
DK166683B1 (en) 1993-06-28
NZ206815A (en) 1986-08-08
CH655507B (en) 1986-04-30
EP0122219A3 (en) 1985-05-08
HUT34151A (en) 1985-02-28
IE56545B1 (en) 1991-08-28
MA20000A1 (en) 1984-10-01
AR240310A1 (en) 1990-03-30
PL142737B1 (en) 1987-11-30
OA07628A (en) 1985-05-23
ATE37378T1 (en) 1988-10-15
DD218373A5 (en) 1985-02-06
FI82682B (en) 1990-12-31
FI82682C (en) 1991-04-10
JPH0257058B2 (en) 1990-12-03
IL70660A (en) 1987-08-31
NL8400098A (en) 1984-08-01
NO840090L (en) 1984-07-13
BE898649A (en) 1984-07-11
IE840049L (en) 1984-07-12
FI840069A (en) 1984-07-13
SE8400098L (en) 1984-07-13
GB2134529A (en) 1984-08-15
HK90390A (en) 1990-11-09
ES8504849A1 (en) 1985-05-01
MTP943B (en) 1984-06-05
PL245656A1 (en) 1985-01-02
AT391467B (en) 1990-10-10
CS17884A2 (en) 1989-10-13
FI840069A0 (en) 1984-01-09
EP0122219A2 (en) 1984-10-17
GR79793B (en) 1984-10-31
NO162862C (en) 1990-02-28
PT77932B (en) 1986-07-22
KR840007562A (en) 1984-12-08
RO88481A (en) 1986-01-30
US4510128A (en) 1985-04-09
DE3400491C2 (en) 1988-11-10
HU190750B (en) 1986-10-28
ZW484A1 (en) 1984-08-08
JPS59134759A (en) 1984-08-02

Similar Documents

Publication Publication Date Title
ATA784A (en) METHOD FOR PRODUCING A LOADED ION EXCHANGE RESIN AND THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS HIEMITE
AT387980B (en) METHOD FOR PRODUCING A FACTOR EFFECTING THE RESOLUTION OF HUMAN CELLS
ATA290884A (en) METHOD FOR PRODUCING A MEDICINAL PRODUCT WITH CONTROLLED AND EVALUATE RELEASE OF THE MEDICINAL ACTIVE SUBSTANCE
DE3888177D1 (en) QUICK-DISCONNECTED MEDICINE DOSING UNIT AND METHOD FOR PRODUCTION.
DD206534A1 (en) METHOD FOR PRODUCING A SOLID SHAPED OBJECT
DE3855137D1 (en) Process for the production of an oxide superconductor
DE3587906D1 (en) Process for producing a coated magnetic powder and pressed magnetic powder core.
DE3855699D1 (en) A method of manufacturing a superconducting article, and apparatus and systems using the article
DE3889398D1 (en) Process for the production of a superconductor.
AT348981B (en) PROCESS FOR THE PRODUCTION OF NEW 5-SULFONAMIDO-2-AMINO-BENZOIC ACID DERIVATIVES AND THEIR ACID ADDITON SALTS
AT376366B (en) METHOD FOR PRODUCING A MEDICINAL PRODUCT
ATA294581A (en) METHOD FOR THE PRODUCTION OF CARAMEL PREPARATIONS IN POWDERED FORM
AT370286B (en) METHOD FOR PRODUCING A MEDICAL DI [TETIC PRODUCT
DE69033230D1 (en) Process for the production of a laminate
AT382236B (en) METHOD FOR PRODUCING A SPLITTER BODY AND SPLITTER BODY PRODUCED THEREFOR
ATA133784A (en) METHOD FOR PRODUCING A NEW THERAPEUTIC PREPARATION CONTAINING CO-DERGOCRINE AND A CALCIUMANTAGONIST
AT374365B (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION
ATE75443T1 (en) PROCESS FOR THE MANUFACTURE OF A LATTICE STRUCTURE AND A LATTICE STRUCTURE.
AT376436B (en) METHOD FOR PRODUCING NEW THIOPHENE-2CARBONS [UREDERIVATIVES AND PHARMACEUTICALLY COMPATIBLE ACID OR BASE ADDITION SALTS THEREOF
DE3853444D1 (en) Process for the production of a superconducting oxide.
AT365452B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
ATA282982A (en) MODELING OR MOLDING AND METHOD FOR THEIR PRODUCTION
AT379936B (en) METHOD FOR THE PRODUCTION OF A CROSS Dough
AT386204B (en) METHOD FOR PRODUCING NEW SUBSTITUTED CARBAPENEMES AND THEIR SALTS
ATA258284A (en) METHOD FOR THE PRODUCTION OF CLAVIN NUT CORNAL CALOIDS AND A STEM PRODUCING THIS ALKALOID

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee